Damora Therapeutics, Inc.

    Damora Therapeutics, Inc.

    NNASDAQ:GLTO
    - -
    USD
    - -
    - -
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    -66.14
    -82.41
    -190.46
    -51.22
    -60.63
    -36.08
    -18.53
    - -
    -158.5
    Free Cash Flow per Basic Share
    -47.65
    -37.86
    -208.86
    -51.99
    -42.43
    -34.73
    -16.09
    - -
    -5.08
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -114.91
    -136.19
    -570.56
    -154.49
    -214.23
    -240.94
    -239.83
    - -
    -368.14
    Tangible Book Value per Share
    -117.75
    -139.37
    904.77
    116.01
    60.76
    30.42
    12.51
    - -
    -132.85
    Basic Weighted Avg Shares
    - -
    1
    - -
    1
    1
    1
    1
    - -
    1
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    - -
    Net Income, GAAP
    -16
    -37
    -35
    -52
    -62
    -38
    -21
    -210
    -210
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    31
    48
    164
    106
    53
    31
    16
    240
    240
    LT Debt
    - -
    - -
    1
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    17
    35
    165
    117
    62
    32
    16
    240
    240
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    1
    1
    416
    Shares Outstanding
    1
    1
    2
    Market Capitalization
    4
    5
    30

    Working Capital

    USD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'25
    Total Current Assets
    13
    10
    260
    Cash, Cash Equivalents & STI
    10
    8
    258
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    3
    3
    20
    Payables & Accruals
    1
    1
    19
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    248.65%
    1,418.41%
    Free Cash Flow
    - -
    -21.65%
    -63.88%
    Net Income, GAAP
    - -
    172.91%
    878.77%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -12.65
    -10.18
    -7.5
    - -
    -36.08
    2024
    -5.05
    -4.92
    -3.39
    - -
    -18.53
    2025
    -1.92
    -2.6
    -2.36
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • zacks.com

      What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?

    • defenseworld.net

      Galecto, Inc. (NASDAQ:GLTO) Given Consensus Recommendation of “Moderate Buy” by Brokerages

    • defenseworld.net

      Galecto, Inc. (NASDAQ:GLTO) Short Interest Up 86.6% in February

    • globenewswire.com

      Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million

    • globenewswire.com

      Galecto Announces Pricing of $275 Million Underwritten Public Offering

    • defenseworld.net

      Galecto, Inc. (NASDAQ:GLTO) Given Average Rating of “Moderate Buy” by Analysts

    • defenseworld.net

      Analysts Set Galecto, Inc. (NASDAQ:GLTO) PT at $41.00

    • defenseworld.net

      Comparing Galecto (NASDAQ:GLTO) and Avidity Biosciences (NASDAQ:RNA)

    • defenseworld.net

      Galecto (NASDAQ:GLTO) Shares Down 13.3% – Time to Sell?

    • globenewswire.com

      Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    • invezz.com

      GLTO, MOVE: two penny stocks quadrupled today – but should you buy?

    • benzinga.com

      Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029

    • globenewswire.com

      Galecto Announces Acquisition of Damora Therapeutics

    • globenewswire.com

      Galecto Reports Third Quarter 2025 Operating and Financial Results

    • benzinga.com

      What's Going On With Nano-Cap Galecto Stock On Tuesday?

    • invezz.com

      Galecto stock skyrockets 600%: why tiny float stocks are market's latest gamble

    • globenewswire.com

      Galecto Reports Second Quarter 2025 Operating and Financial Results

    • https://www.defenseworld.net

      12,701 Shares in Galecto, Inc. (NASDAQ:GLTO) Bought by Squarepoint Ops LLC

    • globenewswire.com

      Galecto Reports First Quarter 2025 Operating and Financial Results

    • globenewswire.com

      Galecto Reports Full-Year 2024 Financial Results